Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
S. Snapinn, M. Chen, Q. Jiang, and T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
H. Brønnum-Hansen. Journal of epidemiology and community health, 53 (5):
300-5(May 1999)4322<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print; JID: 7909766; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
E. Moodie, and D. Stephens. International journal of public health, 56 (1):
117-9(February 2011)6250<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101304551; 2010/05/07 received; 2010/09/12 accepted; 2010/08/01 revised; 2010/10/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Propensity score; Marginal structural models; Introductori.
J. Robins, M. Hernán, and A. Rotnitzky. American journal of epidemiology, 166 (9):
994-1002; discussion 1003-4(November 2007)4950<m:linebreak></m:linebreak>GR: R01-HL080644/HL/NHLBI NIH HHS/United States; GR: R37-AI032475/AI/NIAID NIH HHS/United States; JID: 7910653; CON: Am J Epidemiol. 2007 Nov 1;166(9):985-93. PMID: 17875580; 2007/09/17 aheadofprint; ppublish;.
H. Janes, L. Sheppard, and K. Shepherd. Annals of epidemiology, 18 (10):
792-802(October 2008)4973<m:linebreak></m:linebreak>JID: 9100013; 0 (Air Pollutants); 2008/01/09 received; 2008/05/17 revised; 2008/06/18 accepted; ppublish;.
J. Klein, B. Logan, M. Harhoff, and P. Andersen. Statistics in medicine, 26 (24):
4505-19(October 2007)4622<m:linebreak></m:linebreak>CI: Copyright (c) 2007; GR: R01 CA54706-10/CA/NCI NIH HHS/United States; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
W. Hu, K. Mengersen, P. Bi, and S. Tong. Epidemiology and infection, 135 (2):
245-52(February 2007)4940<m:linebreak></m:linebreak>JID: 8703737; 2006/04/03 accepted; 2006/06/19 aheadofprint; ppublish;<m:linebreak></m:linebreak>Sèries temporals.
J. Beyersmann, P. Gastmeier, M. Wolkewitz, and M. Schumacher. Journal of clinical epidemiology, 61 (12):
1216-21(December 2008)4615<m:linebreak></m:linebreak>JID: 8801383; 2007/08/09 received; 2008/01/10 revised; 2008/02/12 accepted; 2008/07/10 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
H. Bucher, G. Guyatt, L. Griffith, and S. Walter. Journal of clinical epidemiology, 50 (6):
683-91(June 1997)2443<m:linebreak></m:linebreak>Metaanàlisi.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.